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Abstract
Background: We hypothesized that in Flanders (Belgium), the prevalence of at-risk genotypes for genotoxic effects
decreases with age due to morbidity and mortality resulting from chronic diseases. Rather than polymorphisms in
single genes, the interaction of multiple genetic polymorphisms in low penetrance genes involved in genotoxic
effects might be of relevance.
Methods: Genotyping was performed on 399 randomly selected adults (aged 50-65) and on 442 randomly selected
adolescents. Based on their involvement in processes relevant to genotoxicity, 28 low penetrance polymorphisms
affecting the phenotype in 19 genes were selected (xenobiotic metabolism, oxidative stress defense and DNA repair,
respectively 13, 6 and 9 polymorphisms). Polymorphisms which, based on available literature, could not clearly be
categorized a priori as leading to an ‘increased risk’ or a ‘protective effect’ were excluded.
Results: The mean number of risk alleles for all investigated polymorphisms was found to be lower in the ‘elderly’
(17.0 ± 2.9) than the ‘adolescent’ (17.6 ± 3.1) subpopulation (P = 0.002). These results were not affected by gender
nor smoking. The prevalence of a high (> 17 = median) number of risk alleles was less frequent in the ‘elderly’
(40.6%) than the ‘adolescent’ (51.4%) subpopulation (P = 0.002). In particular for phase II enzymes, the mean number
of risk alleles was lower in the ‘elderly’ (4.3 ± 1.6 ) than the ‘adolescent’ age group (4.8 ± 1.9) P < 0.001 and the
prevalence of a high (> 4 = median) number of risk alleles was less frequent in the ‘elderly’ (41.3%) than the
adolescent subpopulation (56.3%, P < 0.001). The prevalence of a high (> 8 = median) number of risk alleles for DNA
repair enzyme-coding genes was lower in the ‘elderly’ (37,3%) than the ‘adolescent’ subpopulation (45.6%, P = 0.017).
Conclusions: These observations are consistent with the hypothesis that, in Flanders, the prevalence of at-risk alleles
in genes involved in genotoxic effects decreases with age, suggesting that persons carrying a higher number of at
risk alleles (especially in phase II xenobiotic-metabolizing or DNA repair genes) are at a higher risk of morbidity and
mortality from chronic diseases. Our findings also suggest that, regarding risk of disease associated with low
penetrance polymorphisms, multiple polymorphisms should be taken into account, rather than single ones.
Background
Cancer and cardiovascular diseases are the main causes
of severe morbidity and mortality in the developed world
[1]. In western populations, morbidity and mortality rates
of cardiovascular diseases, cancer and some other
potentially fatal diseases increase rapidly between 15 and
65 years of age. According to Seer statistics, cancer inci-
dence among non-hispanic whites in the USA in the year
2007 amounted to 19.2 per 100,000 persons below age
20, and to 874.9 per 100,000 persons aged 50 to 64 [2].
Based on rates from 2005-2007, 41.23% of white men and
women born today in the USA will be diagnosed with
cancer of all sites at some time during their lifetime [3].
Similar trends have been observed in Flanders, (an
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industrialized region in Belgium), which is the area under
study in this report [4]. During youth and early adult-
hood, accidents and suicide are the main causes of death
in Flanders. Between age 40 and 69 for women and age
50 and 79 for men, cancer is the main cause of death in
Flanders. Later in life cardiovascular diseases are the
main causes of mortality and severe morbidity [5]. Inci-
dence of cancer steeply rises with age as carcinogenesis
rests on the accumulation of several critical steps in time
(mutations and also epigenetic events). Mortality from
cardiovascular diseases shows an even more pronounced
increase with age than cancer [5]. Without doubt, expo-
sure to genotoxic carcinogens through smoking, con-
sumption of alcohol and through diverse other life style
related exposures or through environmental pollution
importantly contributes to cancer risk [6]. Genotoxic
substances such as those present in tobacco smoke and
in polluted air also contribute to the causation of cardio-
vascular diseases [7]. Ironically, many of these genotoxic
substances would not be health-threatening if they were
not bioactivated through metabolism. Xenobiotic meta-
bolism can be divided into two important phases [8].
During phase I, compounds can be activated by oxidation
reactions resulting in the formation of highly reactive,
electrophilic intermediates. In addition, these metabolic
processes may contribute to the formation of reactive
oxygen species (ROS) [9], which are inactivated by anti-
oxidant defense mechanisms [10]. Electrophilic metabo-
lites may be detoxified in phase II by the conjugation of
endogenous ligands to the activated compounds, thereby
increasing their hydrophilic nature and facilitating urinary
excretion. An imbalance between oxidative metabolism
and detoxification causes reactive intermediate products
to accumulate, which may lead to DNA damage and even-
tually cause mutations. This may be counteracted by sev-
eral DNA repair pathways which are capable of restoring
DNA damage, thereby reducing mutation frequencies in
genes involved in pathogenic processes including carcino-
genesis and atheromatosis [11,12].
As carcinogenesis and atheromatosis ultimately result
from an interaction between genetic and exogenous fac-
tors, variations between individuals in genes involved in
the relevant pathogenic processes might explain to some
degree why certain individuals within the general popula-
tion are at a higher risk of disease, in spite of the fact that
lifetime exposure to potentially hazardous compounds
often does not greatly differ between individuals [13]. In
2008, we published a study conducted in a random selec-
tion of approximately 800 adolescent or elderly indivi-
duals, showing that part of the inter-individual differences
in their reaction towards exposure to genotoxins can
indeed be explained by genotypic differences [14]. It may
consequently be hypothesized that in a random selection
of individuals, able and willing to participate in a
biomonitoring study and exposed to genotoxic substances,
the prevalence of alleles, potentially affecting risk, will shift
towards a higher frequency of the more ‘protective’ geno-
types in ‘elderly’ individuals compared to adolescents, due
to higher rates of morbidity and mortality among subjects
with more unfavorable alleles.
Twin studies show that genetic differences account for
about a quarter of the variance in adult human lifespan
[15]. However, knowledge about genes that contribute to
human longevity is limited. Few studies comparing preva-
lences of different genotypes between age groups exist,
and contradicting results regarding the impact of certain
genotypes on longevity were reported [16-19]. However,
these studies focused mainly on only a few genotypes. Yet,
it is very unlikely that one single low penetrance poly-
morphism is pivotal in carcinogenesis, atheromatosis and
longevity. It is thus crucial to assess multiple genetic poly-
morphisms simultaneously, in order to obtain a better
insight in human susceptibility, and thus longevity, in
response to exposures to genotoxic substances.
Subjects invited to participate in this population-based
biomonitoring study were randomly selected from the
general population in the study area’s comprising 22% of
the surface area of Flanders and 20% of its population.
Participation in the study implied being able to attend
school (for adolescents) or to attend a consultation held
by study nurses in a local community centre (for adults).
Therefore, persons suffering from severe illness were unli-
kely to participate, although not formally excluded.
Available genotypes of 841 adolescents and elderly
adults who participated in the Flemish Environment and
Health Survey (FLEHS) were analyzed in an attempt to
test the hypothesis that at-risk genotypes in relation to
exposure to genotoxic substances decrease with age in a
randomly selected population of persons able and willing
to participate in a biomonitoring study. These adolescents
[20] and adults [21] were shown to be internally exposed
to: polycyclic aromatic hydrocarbons and benzene, long-
time recognized human genotoxic carcinogens; lead and
cadmium, carcinogenic [22] and indirectly genotoxic
through disturbance of DNA repair and increasing oxida-
tive stress [23-25]; and to the persistent organochlorines
polychlorobiphenyls (PCBs), hexachlorobenzene and p,p’-
dichlorodiphenyldichloroethylene (DDE), potentially
increasing oxidative stress [26].
Methods
Study Population
In the Flemish Environment and Health Survey (FLEHS)
a Stratified Clustered Multi-Stage Design was used as
described for adults by De Coster et al. [21] and for ado-
lescents by Schroijen et al. [20] to include 1,583 adults
(775 men and 808 women) aged 50 to 65 (mean age:
57.6) and 1679 adolescents with a mean age of 14.9 years
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(range: 13.8-16.5) as a random sample of the population
of the 8 areas under study, comprising 22% of the surface
of Flanders and 20% of its population. The primary stage
in the selection of adults was based on municipalities,
and all contacted municipalities collaborated; concerning
the adolescents, 42 of the 50 schools that were contacted
collaborated. Table 1 shows the numbers of subjects
selected using a Stratified Clustered Multi-Stage Design,
the number of subjects participating in the FLEHS, and
the number of subjects for whom genotyping was per-
formed. The adolescents willing to participate had to
attend a consultation with the study nurses in their
respective schools where sampling of urine and blood,
weighing, measuring and filling out of a self administered
questionnaire took place. The adults willing to participate
had to attend a consultation with the study nurses in a
local community centre where sampling of urine and
blood, weighing, measuring and filling out of a self admi-
nistered questionnaire took place. So participants had to
travel some distance in order to participate. Therefore,
persons suffering from severe illness were unlikely to par-
ticipate, although not formally excluded. Among the total
of 1,583 adults participating in the FLEHS, DNA was
available for analysis from a subset of 399 randomly
selected individuals (176 females and 204 males). Among
the 1679 adolescents, DNA was available for analysis
from a subset of 442 randomly selected individuals (182
females and 260 males). A small proportion (N = 47;
11%) of the adolescents reported to smoke 7 ± 7 cigar-
ettes per day and 63 adult individuals (16%) currently
smoked 17 ± 10 cigarettes per day. Individuals who
reported to have an ethnic background other than Cauca-
sian, were excluded from analysis, because the prevalence
of certain genotypes may differ between races [27].
Further inclusion criteria were living in Flanders for
more than 5 years, and being able to complete question-
naires in Dutch. The study was approved by the ethical
committee of the University of Antwerp, and every indi-
vidual signed an informed consent prior to sample
collection.
White blood cell and DNA isolation
Immediately after blood collection, white blood cells
were isolated by lysing erythrocytes using standard pro-
cedures and total white blood cells were stored as cell
pellets at -80°C until DNA isolation. DNA was isolated
in 96 wells plates using the Invisorb® Blood Midi HTS
96 Kit/C (Invitek, Berlin, Germany), and DNA was sub-
sequently stored in 96 wells plates at -20°C prior to gen-
otyping at a concentration between 40 and 100 ng/μl.
Selection of Polymorphisms and Genotyping
28 Low penetrance polymorphisms in 19 genes were
selected. This selection was based on the involvement of
the genes in processes relevant to genotoxicity thereby
focusing on the commonly studied susceptibility genes in
xenobiotic metabolism, oxidative stress defense and DNA
repair (respectively 13, 6 and 9 polymorphisms, Table 2).
Polymorphisms were selected in function of affecting the
phenotype and having a minimum prevalence of 5%.
Moreover, polymorphisms which could not clearly be
categorized a priori as leading to an ‘increased risk’ or a
‘protective effect’ based on available literature data (see
statistical analysis), were excluded from the analysis.
Genotyping was performed using the SNaPShot multi-
plex genotyping method described earlier [28]. Geno-
types were determined in 4 different multiplex reactions
(Table 2). For each multiplex PCR reaction, Tm was opti-
mized: 56°C for multiplex 1, 60°C for multiplex 2, 57°C
for multiplex 3 and 60°C for multiplex 4. Each of the
multiplex PCR products was subsequently genotyped in a
corresponding multiplex SBE reaction and analyzed on
an ABI Prism® 3100 genetic analyzer using Genescan™
Analysis software (Version 3.7).
Statistical Analysis
Risk alleles were identified based on expected phenotypic
effects of the polymorphisms (Table 2). Genotypes were
subsequently coded based on the number of risk alleles:
homozygous carriers of alleles conferring an increase in
risk were coded 2, carriers of 2 alleles with a putative
protective health effect were coded 0 and heterozygous
genotypes were coded 1. In case of GSTT1 and GSTM1,
wild-types were coded 0 and deletions were coded 2; het-
erozygous individuals for these could not be identified
with the SNaPshot procedure. For each individual, a sum
of risk alleles was computed for all polymorphisms taken
together and also for the processes of biotransformation,
biotransformation phase I (CYP450s), biotransformation
phase II (GSTs and NATs), oxidative stress and DNA
repair separately. Differences between the two age groups
concerning these sums of risk alleles were initially exam-
ined using the Mann-Whitney U test. Additionally, both
for adolescents and adults, and for each of the biological
processes under consideration, we determined the num-
ber of persons who showed more than the median num-
ber (based on the whole study population) of risk alleles.
These persons were considered to carry a “high” number
of risk alleles, whereas the remaining were considered to
carry a “low” number of risk alleles. The prevalence of
Table 1 Numbers of persons selected, participating in the
Flesh and for whom genotyping was performed
Invited Participated (%) Genotyped1 (%)
Adolescents 2870 1679 (58.5%) 442 (15.4%)
Adults 4386 1583 (36.1%) 399 (9.1%)
1Randomly selected among the participants.
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these “low” and “high” sums of risk alleles for each biolo-
gical pathway were compared between the two age-
groups by Chi-Square analysis using a 2 × 2 cross table.
The number of persons included is large enough to
detect a difference of 10% in the prevalence of a “high”
number of risk alleles at an alpha error level of 5% with a
statistical power of 82.7%. All statistical analyses were
conducted using SPSS for windows, version 13.0. Results
are presented as mean ± standard deviations.
Results
In total, 23,548 genotypes were determined. Table 3
shows, per polymorphism, the numbers and percentages
of adolescents and “elderly” with risk alleles. The theore-
tical maximum sum of risk alleles present in an indivi-
dual, computed from this selection of polymorphisms,
is: 28 polymorphisms genotyped per individual * 2 puta-
tive risk alleles = 56 risk alleles. The actual mean of the
individual sum of risk alleles was 17.3 ± 3.0, with a
range from 8 to 27 risk alleles. The mean sum of risk
alleles for all investigated polymorphisms was found to
be significantly lower in the ‘elderly’ (17.0 ± 2.9, range 8
to 25) compared to the adolescent (17.6 ± 3.1, range 10
to 27) population (P = 0.002). Nor in the adolescent nor
in the “elderly” age group the results were affected by
gender or smoking. In addition, subgroups of either a
Table 2 Overview of the selected SNPs, their effect on enzyme function and definition of risk alleles
Polymorphism Expected effect on enzymatic
function
Putuative Risk
Allele
Risk Allele leading to
Biotransformation Phase I
CYP1A2 A > C-154 (1) Higher inducibility -154C
CYP1A1 T > C3801 (4) 3801C
I462V (4) 462V Increased formation of reactive metabolites (phase I
enzymes)
T461N (4) Higher enzyme activity 461N
CYP2E1 G > T-70 (4) -70T
CYP3A4 A > G-391 (4) -391G
Biotransformation Phase II
GSTM1 Del (1) Deletion, no enzyme activity Del
GSTT1 Del (1) Del
GSTP1 I105V (1) 105V Decreased detoxification of reactive metabolites (phase II
enzymes)
A114V (1) 114V
NAT2 I114T (1) Decreased enzyme activity 114T
R197Q (1) 197Q
G286E (1) 286E
DNA Repair
BRCA2 5’UTR (A-
26G)
(2) Modulated expression A-26
N372H (2) Decreased enzyme activity 372H Decreased DNA repair
XRCC1 R194W (2) Increased enzyme activity R194
R280H (2) Decreased enzyme activity 280H
XRCC3 T241M (2) 241M
XPD K751Q (2) 751Q
R156R (2) Decreased enzyme activity 156R Decreased DNA repair
APE1 D148G (3) 148G
OGG1 S326C (2) 326C
Oxidative Stress
mnSOD V16A (3) Decreased enzyme activity 16A
CAT C > T-262 (3) Lower catalase activity -262T Decreased oxidative stress defense
NQO1 P187S (3) Decreased enzyme activity 187S
R139W (3) 139W
MPO G > A-463 (4) Higher enzyme activity G-463 Higher production of free radicals
GPX1 P198L (3) Less efficient final GSH peroxidaxe
complex
198L Impaired GSH metabolism; higher oxidative stress
(1)-(4): different multiplex PCRs (See Materials and Methods).
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“low” or a “high” sum of risk alleles were defined, the
cut-off point being determined by the median sum of
risk alleles in the whole population, namely 17 risk
alleles. The prevalence of a “high” sum of risk alleles
(> 17 risk alleles) was significantly less frequent in the
‘elderly’ (40.6%) as compared to the adolescent (51.4%)
subpopulation (P = 0.002, Chi-Square analysis) (see
Table 4). Subsequently, differences in prevalence of risk
alleles between the two age groups were examined for
different biological processes (biotransformation, Phase I
enzymes, phase II enzymes DNA repair and oxidative
stress) separately.
Biotransformation Pathway
For all polymorphisms in biotransformation-related
genes, the mean number of risk alleles was significantly
lower in the ‘elderly’ age group (5.4 ± 1.9) as compared
to the adolescent age group (5.8 ± 2.2, P = 0.003). Again,
a cut-off sum of risk alleles in biotransformation enzymes
was assessed based on the median value, namely 5. The
presence of a relatively “high” sum of risk alleles in all
selected biotransformation enzymes (> 5 risk alleles) was
less frequent in the ‘elderly’ (44.4%) as compared to the
adolescent population (54.3%, P = 0.005) (Table 4). The
sum of risk alleles coding for biotransformation enzymes,
Table 3 Percentages of adolescents and “elderly” persons with risk alleles
Gene Risk
Allele
Adolescents %
with 1 risk allele
Elderly % with
1 risk allele
Adolescents %
with 2 risk alleles
Elderly % with
2 risk alleles
Adolescents mean
number of risk alleles
Elderly mean
number of risk
alleles
Biotransformation Phase I
CYP1A2 -154C 32.3 36.8 7.3 7.0 0,468 0,509
CYP1A1 3801C 15.1 21.1 2.3 3.3 0,197 0,276
CYP1A1 462V 6.9 6.3% 0.0 0.0 0,069 0,063
CYP1A1 461N 7.6 7.8 0.5 0.0 0,085 0,078
CYP2E1 -70T 6.0 8.8 0.0 0.5 0,060 0,098
CYP3A4 -391G 6.0 5.8 1.1 0.5 0,083 0,068
Biotransformation Phase II
GSTM1 Del n.a.1 n.a.1 56.6 53.4 1,136 1,068
GSTT1 Del n.a.1 n.a.1 18.4 14.3 0,367 0,286
GSTP1 105V 52.3 47.4 16.8 10.5 0,859 0,684
GSTP1 114V 12.5 14.5 2.5 1.0 0,175 0,165
NAT2 114T 49.9 49.6 30.6 19.8 1,113 0,892
NAT2 197Q 39.9 42.9 8.8 6.5 0,576 0,559
NAT2 286E 3.9 5.5 0.0 0.3 0,039 0,060
DNA Repair
BRCA2 A-26 29.9 38.2 3.7 6.1 0,375 0,504
BRCA2 372H 46.2 41.5 9.4 10.6 0,657 0,628
XRCC1 R194 11.0 12.7 0.5 0.8 0,120 0,142
XRCC1 280H 9.7 9.4 0.5 0.3 0,108 0,099
XRCC3 241M 49.8 44.1 16.4 19.5 0,829 0,830
XPD 751Q 42.8 49.9 14.5 11.1 0,720 0,722
XPD 156R 43.7 51.9 24.6 19.7 0,933 0,914
APE1 148G 48.3 47.5 25.2 27.9 0,989 1,033
OGG1 326C 37.2 35.9 7.1 6.6 0,517 0,491
Oxidative Stresss
mnSOD 16A 51.7 51.3 22.4 24.1 0,968 0,995
CAT -262T 30.0 31.7 9.8 8.8 0,499 0,494
NQO1 187S 13.3 5.3 0.2 0.3 0,140 0,058
NQO1 139W 31.1 31.4 4.6 4.3 0,405 0,399
MPO G-463 32.0 36.8 4.6 4.0 0,411 0,449
GPX1 198L 41.6 43.2 7.6 8.8 0,570 0,608
1Not available.
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was further subdivided into those coding for enzymes
involved in bio-activation (phase I) and in detoxification
(phase II) reactions. For phase II enzymes, the mean
number of risk alleles was significantly lower in the
‘elderly’ (4.3 ± 1.6 risk alleles) as compared to the adoles-
cent age group (4.8 ± 1.9 risk alleles, P < 0.001, Figure 1).
Comparison of the prevalence of a “high” sum of risk
alleles (cut off at 4 risk alleles, the median value) in phase
II enzymes-coding genes showed a lower frequency of
“high” sums of risk alleles in the ‘elderly’ (41.3%) as com-
pared to the adolescent age group (56.3%, P < 0.001,
Table 4). The number of risk alleles in genes coding for
phase I enzymes was similar in the two age groups, with
a mean of (1.1 ± 1.0) among the “elderly” and (1.0 ± 1.0)
among the adolescents.
DNA Repair pathway
For DNA repair enzymes, the mean number of risk alleles
was slightly lower in the ‘elderly’ (8.07 risk alleles) as com-
pared to the adolescent age group (8.25 risk alleles) but
the difference was not statistically significant (p = 0.15).
Comparison of the prevalence of a “high” sum of risk
alleles (cut off at the median value of 8 risk alleles) for
DNA repair enzyme-coding genes showed a lower fre-
quency of “high” sums of risk alleles in the ‘elderly’
(37,3%) as compared to the adolescent age group (45.6%,
P = 0.017, Table 4, Figure 2).
Oxidative Stress pathway
The number of risk alleles in genes coding for oxidative
stress-related genes was similar in the two age groups,
with a slightly lower mean number of risk alleles among
the “elderly” (4.1 ± 1.4) than among the adolescents (4.2 ±
1.4) (p = 0.58 ). A “high” number of risk alleles in oxidative
stress-related genes was defined as > 4 (median value = 4).
The presence of a “high” number of risk alleles was slightly
less frequent in the “elderly” (37.3) as compared to the
adolescents (40.5) (Table 4), but this difference was not
statistically significant (p = 0.35).
Discussion
We hypothesized that, in Flanders (an industrialized
region in Belgium), the prevalence of an at-risk genotype
-associated with a higher sensitivity to genotoxic agents-
decreases with age due to morbidity and mortality result-
ing from chronic diseases. In our study, the prevalence of
at risk genotypes (all genes considered taken together) in
the elderly population was indeed observed to be lower
than in the adolescent population. For the different biolo-
gical processes taken separately, a statistically significant
lower prevalence in the elderly was observed, in particular
for phase II biotransformation genes. Among the elderly,
the prevalence of a high number of unfavorable poly-
morphisms in DNA repair genes was also significantly
lower. For genes involved in oxidative stress, a similar but
statistically non-significant trend was observed. Our
results suggest that Flemish residents carrying more unfa-
vorable genetic traits related to genotoxic effects were
more likely to be severely ill (so as to avoid participation
in a biomonitoring study, participation for which travelling
some distance was required) or to have died before age 50
to 65.
The relation between genetic traits and longevity is very
complex and might well differ in function of the time
interval (e.g. old age versus very old age) [18,29]. Never-
theless, an association was found between polymorphisms
in certain genes and longevity [30,31]. For instance, in an
ethnically homogeneous population, different age groups
showed differences in the prevalence of certain poly-
morphisms in interleukin genes [32]. In particular,
Table 4 Numbers and percentage of adolescents and “elderly” persons with low versus high numbers of risk alleles
Low sum of risk alleles1 High sum of risk alleles1 Chi-Square
Total Adolescents 203 (48.6%) 215 (51.4%) p = 0.002
Elderly 215 (59.4%) 147 (40.6%)
Biotransformation Adolescents 196 (45.7%) 233 (54.3%) p = 0.005
Elderly 204 (55.6%) 163 (44.4%)
Phase I Adolescents 321 (73.8%) 114 (26.2%) p = 0.223
Elderly 258 (69.9%) 111 (30.1%)
Phase II Adolescents 190 (43.7%) 245 (56.3%) p < 0.001
Elderly 233 (58.7%) 164 (41.3%)
Oxidative Stress Adolescents 256 (59.5%) 174 (40.5%) p = 0.348
Elderly 249 (62.7%) 148 (37.3%)
DNA Repair Adolescents 233 (54.4%) 195 (45.6%) p = 0.017
Elderly 247 (62.7%) 147 (37.3%)
1The cut-off point between low and high sum of risk alleles was based on the median number of risk alleles for each specific pathway. A high number of risk
alleles was defined as: Total: > 17 risk alleles; Biotransformation:> 5 risk alleles; Phase I: > 1 risk allele; Phase II: > 4 risk alleles; Oxidative stress: > 4 risk alleles;
DNA repair > 8 risk alleles.
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polymorphisms in genes related to inflammation, oxidative
stress [32-34] and mitochondrial DNA [35] were found to
be associated with differences in longevity. Although there
are some contradictory reports in the literature [36,37]
and although paradoxical effects were reported [18], a ser-
ies of observations indicate that genetic traits in phase II
enzymes, expected on mechanistic terms to increase risk,
are indeed associated in humans with an increase in risk
of cancer [19,38-43] or coronary heart disease [44,45]. In a
cohort of not more than 354 persons Kayaalti et al. [46]
detected an association of the interleukin-6 (IL-6) 174 G/
C promoter region and MT2A -5 A/G core promoter
region single nucleotide polymorphisms (SNPs) with long-
evity in the Turkish population.
Is it plausible to hypothesize that persons, who carry
genetic traits which confer in some way an increased
sensitivity to the pathogenic effects of genotoxic agents,
are more likely to be severely ill or to die from disease
before reaching the age of 50 to 65 years? The answer is
probably yes, because, firstly, the exposure to genotoxic
agents such as fine particles in polluted air, is associated
with a decrease in life expectancy [47]. Secondly, it has
also been shown that persons carrying certain genetic
traits related to DNA repair, oxidative stress or metabo-
lism of genotoxic substances, experience an increased
risk of morbidity and mortality when exposed to geno-
toxic substances [48-50].
It has been established beyond doubt that the general
population in a heavily industrialized region such as Flan-
ders has an internal exposure to heavy metals and geno-
toxic or receptor binding pollutants at a level associated
with multiple biological and health effects [20,21,51-53].
Figure 1 Numbers of risk alleles in Phase II genes among the adolescents and the ‘elderly’. The dashed line represents the cut-off point
between the relatively low (≤ 4) and high (> 4) sum of risk alleles (see methods). Compared to the adolescents there are less “elderly” persons
with five to eleven risk alleles in phase II genes (p < 0.001). Moreover, the mean number of risk alleles is significantly lower in the ‘elderly’
population compared to the adolescent population (P < 0.001). As can be seen from the figure, among the “elderly” the group with 4 at risk
alleles counts the most subjects, more then hundred (107), whereas among the adolescents the group with 5 at risk alleles counts the most
subjects, almost 90 (88).
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Both the adolescent and the adult participants in our
FLEHS biomonitoring study appeared internally exposed
to directly genotoxic agents such as polycyclic aromatic
hydrocarbons, benzene and toluene, to heavy metals
which may indirectly induce genotoxic effects, and to
receptor-binding substances such as PCBs, hexachloro-
benzene and DDE known to induce, at least under some
circumstances, oxidative stress. Many of these pollutants
are substrates for phase II detoxification enzymes [54].
All in all, it seems plausible to hypothesize that unfavor-
able alleles of genes involved in avoidance of genotoxic
effects and in particular of genes involved in phase II
detoxification are indeed associated with early severe
morbidity and early mortality. Also, it is probable that
the morbidity and mortality of persons carrying a high
number of unfavorable genetic traits will differ more
from morbidity and mortality of persons at younger age
(under age 65) than at very old age, when morbidity and
mortality are high among all persons.
Our findings regarding phase II genes are consistent
with results from several case-control studies which have
previously reported an association between polymorph-
isms in NAT, GSTM and GST and various types of cancer
[19,38-43,55,56] or coronary heart disease [44,45]. It is
remarkable that in our study the suggested negative asso-
ciation between unfavorable genetic traits and reaching
age 50-65 without severe morbidity was most pronounced
in relation with phase II enzymes, whereas it was less pro-
nounced in relation to DNA repair genes. Interestingly,
Laczmanska et al. [57] found that polymorphisms in genes
encoding for xenobiotic metabolizing enzymes, had a
greater influence on the genotoxic effect of diepoxybutane
than polymorphisms in genes encoding for DNA repair
proteins, which underlines our findings.
Figure 2 Numbers of risk alleles in DNA repair genes among the adolescents and the ‘elderly’. The dashed line represents the cut-off
point between the relatively low (≤8) and high (> 8) sum of risk alleles (see methods). The number of persons with nine to fourteen at-risk
alleles is smaller among the elderly (p = 0.017). As can be seen from the figure, among the “elderly” the group with 8 at risk alleles counts the
most subjects, more then hundred (109), whereas among the adolescents the group with 9 at risk alleles counts the most subjects, more the
hundred (104).
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For genes involved in oxidative stress, the distribution
of “low” and “high” sums of risk alleles between both
age groups showed the same trend with lower numbers
of risk alleles in the elderly, but this difference was very
small and far from statistically significant. Conceivably,
our “elderly” population was not old enough to allow
differences with adolescents in oxidative stress to be sta-
tistically significant.
The cross-sectional design of the current study and the
rather small number of subjects involved have to be con-
sidered important limitations. Additional observations,
including preferably a prospective study, are certainly
needed to substantiate this particular hypothesis. Still,
the investigated study population appeared large enough
to detect statistically significant differences between the 2
age groups. In addition, the genetic heterogeneity in the
study population can be expected to be limited, as all
participating individuals were Dutch-speaking Caucasians
selected within the same regions in Flanders, and gender
differences between the sub-populations were absent.
Conclusions
The findings in this study may endorse the hypothesis that
the prevalence of a high number of at-risk alleles in genes
involved in genotoxic effects, especially in phase II bio-
transformation genes, decreases with age in a randomly
selected population, suggesting that persons carrying a
higher number of at risk alleles (especially in phase II xeno-
biotic-metabolizing or DNA repair genes) are at a higher
risk of morbidity and mortality from chronic diseases. Our
findings, as those of Rotunno et al [58], also suggest that,
regarding risk of disease associated with low penetrance
polymorphisms, multiple polymorphisms should be taken
into account, rather than single ones. These results further
suggest that it is of importance to continue the debate
about the relevance of inter-individual differences in sus-
ceptibility with regard to human health risk assessment.
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